David Sinclair’s group has published (in a rush) their work on the health and longevity benefits of Resveratrol in mice. Nicholas Wade has good coverage in the NYTimes and Nature has a podcast, a news article, and the research article.
In Wade’s article, Sinclair says he, his family, and his lab are taking it at a lower dose than that reported in the Nature article. Have any of you been taking it? Wikipedia, for what it’s worth, suggests there are problem with pharmacokinetics in pure resveratrol preparations.
I assume that resveratrol itself cannot be patented, but Sinclair’s company is reportedly in the middle of clinical trails with a patentable (and more effective?) resveratrol analog.
Comments are closed.